Global Equity
passive
RISE Global Obesity Industry TOP2+ (476310)
Update : 2026.06.19
NAV
10,373KRW
-80.27하락 (-0.77%)
Market Price per share (KRW)
10,310KRW
-40하락 (-0.39%)
※ t-1 last price
trading volume
5,142shares
AUM
KRW 5.7billion
KEY POINT
Focus on investing in key corporations of the global megatrend in obesity treatment.
KEY POINT
It allocates 28% each to the market's First Mover, Eli Lilly (LLY) and Novo Nordisk (NVO), while the rest is invested in global pharmaceutical and fitness-related companies.
| ETF Name (code) | Benchmark Index | Inception date | Creation Unit | AUM (KRW) |
|---|---|---|---|---|
| KB RISE Global Obesity Care Industry TOP2+ ETF
(476310) |
KEDI Global Obesity Care Industry Top2+ Index | 2024.02.27 | 50,000 | 5,704,945,651 |
| Trustee | Market Price per share (KRW) | NAV | Trading Volume (shares) | |
| 한국씨티은행 |
10,310
※ t-1 last price |
10,372 | 5,142 |
| Total Expense Ratio | Distribution Frequency |
|---|---|
| Year 0.35% (Designated participating company : 0.01%, Collective investment : 0.3%, trust : 0.02%, General affairs : 0.02%) | Last business day of January and July |
| Authorized Participants | Liquidity Providers |
| Kiwoom Securities, NH Investment & Securities, Shinhan Investment & Securities, Korea Investment & Securities, Mirae Asset Securities | Kiwoom Securities, NH Investment & Securities, Shinhan Investment & Securities, Korea Investment & Securities, Mirae Asset Securities |
| ETF Name(Code) | Benchmark Index |
|---|---|
|
KB RISE Global Obesity Care Industry TOP2+ ETF (476310) |
KEDI Global Obesity Care Industry Top2+ Index |
| Inception date | Creation Unit |
| 2024.02.27 | 50,000 |
| AUM(0.1 billion) (KRW) | Trustee |
| 5,704,945,651 | 한국씨티은행 |
| Market Price per share (KRW) | iNAV per share (KRW) |
|
10,310
※ t-1 last price |
10,372 |
| Trading Volume (shares) | |
| 5,142 |
| Total Expense Ratio |
|---|
| Year 0.35% (Designated participating company : 0.01%, Collective investment : 0.3%, trust : 0.02%, General affairs : 0.02%) |
Distribution Frequency
|
| Last business day of January and July |
| Authorized Participants |
| Kiwoom Securities, NH Investment & Securities, Shinhan Investment & Securities, Korea Investment & Securities, Mirae Asset Securities |
| Liquidity Providers |
| Kiwoom Securities, NH Investment & Securities, Shinhan Investment & Securities, Korea Investment & Securities, Mirae Asset Securities |
Index Introduction
The KEDI Global Obesity Industry Top2+ Index is comprised of companies in the obesity industry, a global megatrend. It allocates 28% of its composition to Eli Lilly (LLY) and Novo Nordisk (NVO), the first movers in the obesity treatment market, and the remainder to global pharmaceutical companies and fitness-related enterprises, utilizing a market capitalization-weighted method.
TOP 10 Holdings
Update : 2026-06-19
| Rank | Name | Weight (%) |
|---|---|---|
| 1 | NOVO NORDISK AS SPONS ADR | 28.04 |
| 2 | ELI LILLY & CO | 27.94 |
| 3 | NORVARTIS AG ADR | 8.77 |
| 4 | MERCK & CO.INC | 8.67 |
| 5 | AstraZeneca PLC | 8.26 |
| 6 | AMGEN INC | 4.99 |
| 7 | ABBOTT LABORATORIES | 3.93 |
| 8 | Life Time Group Holdings Inc | 3.21 |
| 9 | DICKS SPORTING GOODS INC | 3.09 |
| 10 | LULULEMON ATHLETICA INC | 2.71 |
proportion by sectors
*The proportion of investment stocks
Update : 2026.06.19
| Rank | Name | Weight (%) |
|---|---|---|
| 1 | Health Care | 90.53 |
| 2 | Consumer Discretionary | 9.47 |
Dividend payment data
· Payable date of dividend payment 3 years.| Rule of Dividend payment | Payable date of dividend payment | dividend per share (KRW) |
|---|---|---|
| 2025-12-30 | 2026-01-05 | 151 |
- Investment notice
- - The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- - Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- - Past performance does not guarantee future profits.
- - In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- - Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- - Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.